Sugammadex versus neostigmine for neuromuscular blockade reversal in adults: A systematic review and meta-analysis of randomised controlled trials
Pooled result · Time to reversal of NMB from second twitch to a train-of-four ratio more than 0.9Result — go to the resultMean difference −10.49 min 95% CI −11.90 to −9.08Authors' conclusion
Sugammadex probably reverses NMB more rapidly and with fewer adverse events than neostigmine. Broader use of sugammadex has the potential to improve peri-operative outcomes.
Study context
- Population
- Adults receiving rocuronium or vecuronium for elective proceduresparticipants in 165 trials
- Participants
- 19,124 adults
- Comparison
- Sugammadex compared with neostigmine
- Outcome
- Time to reversal of NMB from second twitch to a train-of-four ratio more than 0.9
Methodological detailsCertainty of evidence assessed using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) framework, update of a 2017 Cochrane review, Online databases searched up to December 2025
- Certainty of evidence assessed using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) framework
- Update of a 2017 Cochrane review
- Online databases searched up to December 2025
Pooled result
As reported in the abstract
Time to reversal of NMB from second twitch to a train-of-four ratio more than 0.9
Mean difference
−10.49 min
95% CI −11.90 to −9.08
Sugammadex 2 mg kg-1vs Neostigmine 0.05 mg kg-1
mean difference −10.49 min (95% CI −11.90 to −9.08)
Further findings
Conduct of the included trials
- Risk of bias was generally unclear or high.
- Neuromuscular blockade (NMB) monitoring technique was reported in 113 trials, mostly acceleromyography.
Safety
| Outcome | Risk ratio (95% CI) | |
|---|---|---|
| Patients with at least one adverse eventGRADE: moderate | 0.72 (0.61–0.84) | |
| 0.512Risk ratio (log scale) |
Specific adverse events
- Sugammadex probably reduces the risk of residual NMB, inadequate NMB reversal, desaturation, atelectasis, increased upper airway secretion, airway obstruction, bradycardia, dry mouth and urinary retention (GRADE: moderate)
Original publication
Sugammadex versus neostigmine for neuromuscular blockade reversal in adults: A systematic review and meta-analysis of randomised controlled trials. Eur J Anaesthesiol. Published 3 November 2026. doi:10. 1097/ eja. 0000000000002526
Composed by AI from the published abstract and checked against it. How Briefs are made →